We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

DAC:NYSEDanaos Corporation Analysis

Data as of 2026-06-13 - not real-time

$131.30

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Danaos Corporation is trading in a bullish technical environment, with the price comfortably above its 20‑day and 50‑day moving averages. The 200‑day average remains well below the current price, underscoring a long‑term uptrend. Momentum indicators, however, show a bearish MACD crossover and a negative histogram, suggesting short‑term pressure. Trading volume has been declining, which could limit upward thrust as the stock approaches a key resistance zone. Fundamentals are exceptionally strong: profit margins exceed 45%, cash flow generation comfortably covers debt, and the payout ratio is modest, supporting dividend sustainability. The price‑to‑earnings multiple is dramatically lower than the sector average, while the price‑to‑book ratio is well under one, indicating an value‑oriented pricing.
Yet the discounted cash‑flow model places intrinsic value well beneath the market price, hinting at overvaluation on a cash‑flow basis. Recent earnings releases beat expectations, driven by higher adjusted EPS and a robust backlog of contracted revenue. Management highlighted continued fleet expansion and a healthy order book, which should support earnings growth in the medium term. With a dividend yield near three percent and a low payout, the dividend appears sustainable even under modest earnings volatility. Overall, the stock presents a mixed picture: strong value metrics and earnings momentum counterbalanced by technical weakness and a premium to DCF valuation. Investors should weigh the near‑term technical risk against the longer‑term fundamentals and dividend appeal.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD crossover
  • Approaching resistance with decreasing volume
  • Technical weakness despite bullish trend

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Earnings beat and strong backlog
  • Low valuation multiples relative to industry
  • Sustainable dividend with low payout

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Fleet expansion pipeline
  • Exposure to global trade cycles
  • Dividend yield and cash flow coverage

Key Metrics & Analysis

Financial Health

Revenue Growth0.20%
Profit Margin49.85%
P/E Ratio4.6
ROE14.03%
ROA6.58%
Debt/Equity26.17
P/B Ratio0.6
Op. Cash Flow$674.0M
Free Cash Flow$135.0M
Industry P/E30.6

Technical Analysis

TrendBullish
RSI58.5
Support$122.57
Resistance$134.78
MA 20$129.55
MA 50$124.83
MA 200$105.03
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86

Valuation

Fair Value$98.69
Target Price$157.00
Upside/Downside19.57%
GradeOvervalued
TypeValue
Dividend Yield2.74%

Risk Assessment

Beta0.63
Volatility23.80%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.